Many of us who have been infected with the COVID-19 virus face long-term health challenges, including lung nodules, severe complications, and surgery. Current treatments for these long-term effects are still limited. This article introduces the potential of exosome therapy, a cutting-edge treatment, to address COVID-19 syndrome, particularly its neurological and mental health aspects and its benefits for the heart and lungs.
Dr. Philip W. Askenase, a professor of immunology at the Yale University School of Medicine, proposed in an academic journal that extracellular vesicle therapy should be used to treat the main central nervous system symptoms of COVID-19 syndrome. Extracellular vesicles are particles released by cells, and exosomes are one type of extracellular vesicles.





